Dry powder inhaler

Selecting a DPI requires a focus on aerosol performance and patient compliance. You must prioritize devices that ensure a high Fine Particle Fraction (FPF), typically above 30-50%, to ensure the medication reaches the deep lungs. Evaluate the internal resistance of the device (low, medium, or high) to match the target patient demographic's inspiratory flow capabilities. Ensure the device uses medical-grade, BPA-free plastics and features a dose counter to prevent patients from using empty inhalers.

As a medical device, DPIs must adhere to strict international standards. Ensure the manufacturer holds ISO 13485 certification for medical device quality management. Products should be CE marked (MDR 2017/745) for the European market or have FDA 510(k) clearance for the U.S. market. Additionally, verify that the device meets ISO 20072:2009 standards, which specify the design verification of aerosol drug delivery devices.

Key technical factors include moisture protection, as powder clumping significantly reduces efficacy; look for devices with integrated desiccant or high-barrier blister seals. The de-agglomeration mechanism (e.g., cyclone chambers or mesh) is critical for breaking down powder into respirable sizes. Furthermore, the uniformity of delivered dose (UDD) must be validated through third-party lab reports to ensure consistent medication delivery across all doses.

Analyze the Total Cost of Ownership (TCO) by comparing single-dose (capsule-based) vs. multi-dose (reservoir or blister-based) systems. While multi-dose devices have a higher unit cost, they offer better patient adherence and convenience, potentially commanding higher market prices. For bulk orders, aim for volume discounts of 10-20% on quantities exceeding 10,000 units, and always factor in the cost of sterile medical packaging.

The biggest risks are regulatory rejection at customs and intellectual property (IP) infringement. Ensure the supplier provides a Declaration of Conformity and that the device design does not violate existing patents held by major pharmaceutical firms. Use Made-in-China.com's audited supplier reports to verify the factory's physical existence and production capacity to avoid 'trading company' markups and quality inconsistencies.

Focus negotiations on quality stability and lead times rather than just the lowest price. Request a Quality Agreement (QA) that defines acceptable defect rates (AQL levels). Demand transparency in the raw material supply chain, specifically for the medical-grade polymers used. For long-term contracts, negotiate staggered payment terms (e.g., 30% deposit, 70% after third-party pre-shipment inspection).

DPIs are sensitive to environmental conditions. Shipping must be handled via temperature-controlled logistics (Cold Chain or Controlled Ambient) if the device is pre-loaded with medication. Even for empty devices, ensure humidity-controlled containers to prevent degradation of internal seals. Use Double-Wall Corrugated fiberboard boxes with moisture-proof inner linings to prevent physical damage during cross-border transit.

Always utilize secure payment gateways provided by reputable platforms like Made-in-China.com, which offer escrow-like services. Never wire full payments to private accounts. Engage a third-party inspection agency (like SGS or Intertek) to perform a 'During Production Check' (DUPRO) and a 'Final Random Inspection' (FRI) to ensure the goods meet your specifications before they leave the exporter's warehouse.